Ethics concern over outsourcing clinical trial

Last year my company started outsourcing partconducted similar documented illegal trials in
of research and development to  pharmaceuticalcountries like Russia, Nepal, Uganda, Peru, China,
company in India. Cost reduction is definitely aNigeria, and Argentina.
key to better net revenue and that was definitelyIn developing countries, people do not understand
a plus point but it really got me thinking aboutthe concept of clinical trials. Their concept of
other facet of pharmaceutical outsourcing. Iclinical trial is free drug to ease their pain and cure
started searching for pharmaceutical outsourcingtheir disease. There is no formal way of informed
and found out that there is a trend of clinical trialconsent. The data collected in these clinical trials
outsourcing to different developing countries likeare highly doubtful as the patient population is
India. Clinical trial outsourcing is very sensitive andentirely different and the result of the trial may
questionable. Clinical trials in US are FDA regulatednot apply to the targeted population. This means
and laws and regulations are in place. Patients canthat we will put targeted population at risk. Taking
quit the trial period or can be in trial until completeanother example of Hepatitis E trial in Nepal,
at their discretion. Clinical trials are carefullyinvestigators failed to get patients’ consent
conducted and patients are well informed aboutabout changes in the experiment and administered
side effects and covered for all the treatmentswrong doses. There were serious problems in
due to side effects. With increased awarenessrecord keeping and delays and underreporting of
about the risk and side effects of testing drugsfatal and life threatening problems. Fourteen
under development, the volunteers in developeddeaths were not reported. Researchers
countries have shriveled. Due to the reason, theacknowledged thousands of side effects and
drug industry is exponentially moving toadverse reactions were not disclosed. Procedures
underdeveloped and developing countries like Indiafor divulging Serious Adverse Events (SAEs) were
where enrolling uninformed, non consenting poornot followed. Boehringer Ingelheim, the company
people are readily available. Looking at the clinicalthat markets the drug and audited the trial, asked
trial outsourcing data from 1997-2007, US clinicalthe US National Institutes of Health to destroy an
trial declined from 86% to 57% as it is veryearly copy of the research report in case the
expensive due to law suits, and other clinical trialstudy would be audited by FDA. There were
related expense. Clinical trial in developing countriesmany violations such as adverse event
has climbed from 5% to 29% where law suitsnotification, destroying documentation regarding
are unheard of and compensation is minimal.research findings, and side effects were not
I was researching about clinical trial in developingproperly discussed with patient population.
countries and I was shocked to find news aboutGlaxoSmithKline has unethically tested breast
reputed pharmaceutical company Pfizer. Pfizercancer drug in India. About 400 thousand Indian
completed two week trial of an antibiotic during awomen have breast cancer and the clinical trial
1996 meningitis epidemic in Kano, Nigeria. A 2000was the only option as they were vulnerable and
Washington Post story criticized trial investigatorspoor. The only option was to accept the trial and
for allegedly allowing children to die while takingeven the drug is proved to be safe, they cannot
the study drug, sparking lawsuits from familiesafford the drug and the total population the trial
and the Nigerian government. Pfizer reached awas done is unethical. In every controversy
$75 million settlement with Kano in July, accordingregarding outsourcing clinical trials, I have seen
to the reports.reputed pharmaceuticals involved and I wonder
Outsourcing to developing countries have issues,how many of these other unknown clinical trials
the patient population is different, where there isare currently conducting in poor countries.  
no strong FDA regulation, no long term monitoringThere are cases of cheating in clinical trial
system and clinical trials illiteracy. Minor sidedocumentation and it has been an issue so FDA
effects are hard to monitor as in those countriesshould properly regulate clinical trial outsourcing.
patient come to medical representative or hospitalThere comes an issue of transparency between
only after major issues. In India, unethical andpharmaceutical company and patient population. I
even illegal clinical trials has prevailed without fearam not against outsourcing clinical trials but I would
as there is no law to safeguard the interest oflike to plead pharmaceuticals not to accept
volunteer patients and regulatory authorities fail tounethical or questionable clinical trial offered in poor
take actions against such trials. The example ofcountries where people are treated like guinea
illegal and unethical trial conducted in India involvedpigs. They should comply strickly with FDA rules
Sun Pharmaceutical and Novartis in 2006 andand regulations.